Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by echo2


TSTIF

RE:The Most Significant News FDA Has Ever Released re:TOS!!

OK. Instead of "ALL HOSPITALS, GI SUITES, OR HEALTH CARE PROVIDERS WILL...

June 23, 2017

TSTIF

The Most Significant News FDA Has Ever Released re:TOS!!

I have just come across an remarkable and beyond significant new regulation...

June 23, 2017

TSTIF

RE:RE:RE:Grow up and leave

Regarding 'guesses' about Getinge's plans for their $600,000,000...

June 22, 2017

TSTIF

RE:RE:RE:Grow up and leave

It is my understanding that the strategic installs, for example - 2 units...

June 20, 2017

TSTIF

RE:Grow up and leave

I think the point with all this complaining relates directly to Getinge. They...

June 20, 2017

TSTIF

RE:RE:RE:RE:Another Huge Market for the VP4: Dental

Thanks for the feedback on dental sterilization. Also, just FYI, I used...

June 19, 2017

TSTIF

Another Huge Market for the VP4: Dental

http://www.ajicjournal.org/article/S0196-6553(17)30682-X/fulltext "We...

June 17, 2017

TSTIF

RE:RE:RE:RE:RE:Deny The Problem Exists or Solve It?

I stand corrected that at present the lawsuits against Olympus (at least 7...

June 16, 2017

TSTIF

Deny The Problem Exists or Solve It?

The solution Olympus has repeatedly fallen back upon is to stonewall and deny...

June 15, 2017

TSTIF

AJIC Article Re: Inadequate Sterilization of Cystoscopes!!

Again, another study the inadequacy of existing in use protocols, including...

June 15, 2017

TSTIF

RE:RE:Hmmm

Yes, to see Getinge plan a $600 M Canadian financing, completely backed by...

June 15, 2017

TSTIF

"upside potential from this market opportunity is immense"!

Neil Maruoka, MSc, MBA | Analyst | Canaccord Genuity Corp. (Canada...

June 14, 2017

TSTIF

TSO3 is Going to Submit for Olympus AND Pentax Duodenoscopes

TSO3 Expands Duodenoscope Regulatory Filing Strategy Wednesday, June 14, 2017...

June 14, 2017

TSTIF

RE:Early Morning Seller

A few retailers selling lately because they don't know any better than to...

June 12, 2017

TSTIF

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Hmmm.... why now...

House Positions for C:TOS from 20170523 to 20170523 House...

May 25, 2017

TSTIF

RE:RE:RE:RE:RE:RE:RE:RE:RE:Hmmm.... why now...

My record shows a simple transaction of 500,000 sold through 33 and purchased...

May 25, 2017

TSTIF

RE:RE:RE:Hmmm.... why now...

Agree. He just had too many old options that he was granted at very low...

May 25, 2017

TSTIF

TSO3 has 47 Patents or Patents Pending... & New IR Team

Please read the updated May 2017 presentation summary on the web site...

May 23, 2017

TSTIF

Just How Much of a Dent is TOS Making in JNJ's ASP Division?

JNJ is notorious for not making it at all clear what the financials coming...

May 17, 2017

TSTIF

Maruoka Maintains $5.25 Target -"Accumulate at these levels"

TSO3 Inc. | Q1 results ; maintain BUY and C$5.25 target Neil Maruoka MSc...

May 15, 2017

Featured Company